000			02200 a2200601 4500
005			20250518014952.0
264		0	_c20191212
008			201912s 0 0 eng d
022			_a1433-2965
024	7		_a10.1007/s00198-018-4806-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aBliuc, D
245	0	0	_aMortality risk reduction differs according to bisphosphonate class: a 15-year observational study. _h[electronic resource]
260			_bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _cApr 2019
300			_a817-828 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Observational Study
650	0	4	_aAged
650	0	4	_aAlendronate _xtherapeutic use
650	0	4	_aBone Density Conservation Agents _xtherapeutic use
650	0	4	_aCanada _xepidemiology
650	0	4	_aDiphosphonates _xtherapeutic use
650	0	4	_aEtidronic Acid _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOsteoporosis _xdrug therapy
650	0	4	_aOsteoporotic Fractures _xmortality
650	0	4	_aProspective Studies
650	0	4	_aRisedronic Acid _xtherapeutic use
650	0	4	_aRisk Factors
650	0	4	_aRisk Reduction Behavior
700	1		_aTran, T
700	1		_avan Geel, T
700	1		_aAdachi, J D
700	1		_aBerger, C
700	1		_avan den Bergh, J
700	1		_aEisman, J A
700	1		_aGeusens, P
700	1		_aGoltzman, D
700	1		_aHanley, D A
700	1		_aJosse, R G
700	1		_aKaiser, S
700	1		_aKovacs, C S
700	1		_aLangsetmo, L
700	1		_aPrior, J C
700	1		_aNguyen, T V
700	1		_aCenter, J R
773	0		_tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _gvol. 30 _gno. 4 _gp. 817-828
856	4	0	_uhttps://doi.org/10.1007/s00198-018-4806-0 _zAvailable from publisher's website
999			_c29219077 _d29219077